Transfer factor detection method

A method for detecting transposable elements by analyzing TSD sequences at transposon ends in multiple samples addresses the challenge of identifying novel active elements, enabling applications in various fields without relying on reference sequences.

JP2024167376AActive Publication Date: 2024-12-03NAT AGRI & FOOD RES ORG
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2024151554
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-12-26
Filing Date
2024-09-03
Publication Date
2024-12-03
Estimated Expiration
2040-12-25

AI Technical Summary

Technical Problem

The large amount of inactive transposable elements in genomes makes it difficult to detect new active transposable elements from nucleotide sequence information, as most existing methods rely on reference sequences that are not available for all organisms and are inefficient in identifying novel transposable elements.

Method used

A method that detects transposable elements by analyzing pairs of 5' and 3' ends of transposons with different target site duplication (TSD) sequences from two samples, without requiring a reference sequence, by cutting out sequences of a fixed length and identifying pairs with matching or differing TSDs.

Benefits of technology

Enables the detection of novel active transposable elements using next-generation sequencing, applicable to organisms without reference genomes, facilitating applications in medicine, agriculture, and research by identifying transposons that can modify genetic functions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024167376000010
    Figure 2024167376000010
  • Figure 2024167376000011
    Figure 2024167376000011
  • Figure 2024167376000012
    Figure 2024167376000012
Patent Text Reader

Abstract

To provide means for specifying a transfer factor in a sequence.SOLUTION: In a method of the present disclosure, a transfer factor can be detected without requiring information on a reference genome sequence. For example, a transfer factor can be detected from short read analysis of a next-generation sequencer. A method of the present disclosure is usable for detection of a transfer factor of an unknown sequence. Further, a method of the present disclosure is capable of detecting an active transfer factor in which transfer actually occurs. The present disclosure relates to a method, a program, a storage medium or a system for detecting a transfer factor, and a specified transfer factor or use thereof.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to the field of sequence information, particularly information processing of sequence information of biomolecules such as genomes. The present disclosure can be used in the fields of medical, health care, agriculture, forestry, livestock, fisheries, and environmental applications and basic research by detecting transposable elements. [Background technology]

[0002] Many types of transposable elements exist in the genome with various copy numbers, and most of them are inactive due to mutations. The large amount of information on these inactive transposable elements makes it difficult to detect new active transposable elements from base sequence information. Summary of the Invention [Means for solving the problem]

[0003] It is known that when a transposon transposes, a duplication of several bases in the sequence (Target Site Duplication, TSD) may occur at the target site. For example, in the case of a transposon with a TSD size of 5 bases, the sequence of the 5 bases upstream of the 5' end of the transposon is the same as the sequence of the 5 bases downstream of the 3' end of the transposon. Focusing on both ends of the transposon and the TSD, it is considered that the base sequence of the target site of a newly transposed transposon is different for each transposition, and as a result, the sequence of the TSD is different. In the present disclosure, it has been found that it is possible to directly detect transposition without using a reference sequence by detecting a pair of the 5' end and the 3' end of a transposon with different TSD sequences from the base sequences obtained from two samples.

[0004] In the present disclosure, a method for identifying a transposable element in a sequence is provided, comprising: (A) cutting out a sequence of a certain length from genome sequence data by shifting it by one base at a time to generate a set of excision sequences; (B) cutting each of the excision sequences into an n-base-long portion and the remaining portion, and selecting a pair of excision sequences in which the n-base-long portion at the 5'-end and the n-base-long portion at the 3'-end are identical; (C) selecting a pair of excision sequences having corresponding transposable element partial sequences from the selected pairs; and / or (D) selecting a pair of excision sequences having sequences in which the n-base-long portion differs according to genome sequence data as a transposable element corresponding pair from the pair of excision sequences having corresponding transposable element partial sequences. The method may further include additional steps described herein. In the present disclosure, a program for implementing the method or a recording medium for storing the program, or a system therefor may also be provided. Another aspect of the present disclosure relates to the identified transposable element, or the use thereof.

[0005] Examples of this disclosure include the following: (Item 1) A method for identifying a transposable element in a sequence, comprising: (A) extracting sequences of a certain length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (B) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (C) selecting a pair of excision sequences having corresponding transposable element partial sequences from the selected pairs; (D) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data, as transposable element corresponding pairs; A method comprising: (Item 2) The method includes, before the step (B), a step of selecting excision sequences that are different from a set of excision sequences from the first genome sequence data and a set of excision sequences from the second genome sequence data, The method according to the preceding item, wherein the selection of a pair of excision sequences having the same TSD at the 5' end and the 3' end is performed from among excision sequences that are different between the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data. (Item 3) The method according to any of the preceding items, further comprising a step of calculating the frequency of identical excision sequences in the set of excision sequences. (Item 4) The method according to any of the preceding items, further comprising a step of excluding excision sequences having a frequency below a certain level in the set of excision sequences. (Item 5) The method according to any of the preceding items, further comprising a step of identifying a transposable element sequence based on the transposable element correspondence pair. (Item 6) The method according to any one of the preceding items, further comprising a step of confirming the transposition activity of the transposition element. (Item 7) The method according to any one of the preceding items, wherein the transposition activity of the transposable element is confirmed by one or more methods selected from PCR, sequencing, and hybridization. (Item 8) The method according to any one of the preceding items, further comprising repeating steps (B) to (D) by changing n. (Item 9) The method according to any one of the preceding items, wherein n is 3 to 20. (Item 10) The method according to any one of the preceding items, wherein the constant length is 17 to 50 bases long. (Item 11) The method according to any of the preceding items, wherein the corresponding transposable element partial sequence is a transposable element partial sequence having at least 90% identity. (Item 12) The method according to any of the preceding items, wherein the corresponding transposable element partial sequence is a transposable element partial sequence having at least 95% identity. (Item 13) The method according to any of the preceding items, wherein the corresponding transposable element partial sequences are identical transposable element partial sequences. (Item 14) A method according to any of the above items, wherein the step of generating a set of excised sequences includes excising the fixed length of sequence by shifting it by one base for the complementary strands of the first genome sequence data and the second genome sequence data. (Item 15) A program for causing a computer to execute a method for identifying a transposable element in a sequence, the method comprising: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (d) selecting from the selected pairs a pair of excision sequences having corresponding transposable element partial sequences; (e) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as transposable element corresponding pairs; Including, the program. (Item 15-1) The program described in the above item, further comprising any one or more of the features described in the above item. (Item 16) A recording medium storing a program for causing a computer to execute a method for identifying a transposable element in a sequence, the method comprising: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (d) selecting from the selected pairs a pair of excision sequences having corresponding transposable element partial sequences; (e) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as transposable element corresponding pairs; A recording medium including: (Item 16-1) A recording medium according to any one or more of the preceding items, further comprising the features described in any one or more of the preceding items. (Item 17) A system for identifying a transposable element in a sequence, the system comprising one or more processors, a memory, and a recording medium storing a program, the program, when executed by the one or more processors, performing the following: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) Each of the excised sequences is divided into a sequence corresponding to a target site duplication (TSD) of n bases in length. and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the 5'-end TSD and the 3'-end TSD are identical; (d) selecting from the selected pairs a pair of excision sequences having corresponding transposable element partial sequences; (e) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as transposable element corresponding pairs; A system implementing a method including: (Item 17-1) The system described in the above item, further comprising any one or more of the features described in the above item. (Item 18) A system for identifying a transposable element in a sequence, the system comprising: (A) a sequence data receiving unit that receives first genome sequence data and second genome sequence data; (B) extracting sequences of a certain length from the first genome sequence data and the second genome sequence data obtained by the sequence data receiving unit by shifting the sequences by one base at a time, and generating a set of sequences extracted from the first genome sequence data and a set of sequences extracted from the second genome sequence data; Each of the excision sequences is classified into a sequence corresponding to a target site duplication (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical is selected; From the selected pairs, a pair of excision sequences having corresponding partial sequences of transposable elements is selected; a transposable element matching pair selection unit that executes a step of selecting, from pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different sequences in the TSDs in a set of excision sequences from the first genome sequence data and a set of excision sequences from the second genome sequence data, as transposable element matching pairs; (C) a display section showing the transposable element correspondence pair; Including, the system. (Item 18-1) The system described in the above item, further comprising any one or more of the features described in the above item. (Item 19) A nucleic acid having at least a partial sequence of a transposable element identified by the method according to any one of the preceding items. (Item 20) The nucleic acid described in the above item, which has a recognition sequence for a transferase in the transposable element. (Item 21) Use of the nucleic acid according to any of the preceding items for introducing mutations into a genome sequence. (Item 22) Use of a nucleic acid according to any one of the preceding items for gene disruption by transposition of a transposable element. (Item 23) Use of a nucleic acid according to any of the preceding items for controlling transcription. (Item 24) Use of the nucleic acid according to any of the preceding items for the production of an insertion mutant line.

[0006] The present disclosure further provides: (Item A1) A method for identifying a transposable element in a sequence, comprising: (A) extracting sequences of a certain length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (B) For each of the excised sequences, a portion containing a sequence corresponding to a target site overlap (TSD) of n bases in length is distinguished from a portion not containing a sequence corresponding to the TSD, and a portion containing the same TSD is distinguished from a portion containing the same TSD. Selecting a pair of excision sequences comprising: (C) selecting a pair of excision sequences having corresponding transposable element partial sequences from the selected pairs; (D) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data, as transposable element corresponding pairs; A method comprising: (Item A2) The method according to the above item, wherein step (B) is a step of distinguishing between a sequence corresponding to the TSD and a sequence other than the TSD (transposable element partial sequence) and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical. (Item A3) The method according to any of the above items, wherein step (B) is a step of distinguishing between a portion containing a sequence corresponding to the TSD and a portion not containing a sequence corresponding to the TSD, and selecting a pair of excision sequences containing the same TSD from an excision sequence containing a sequence corresponding to the TSD at the 3'-end of the first half and an excision sequence containing a sequence corresponding to the TSD at the 5'-end of the second half. (Item A4) The method according to any one of the above items, wherein distinguishing between a portion containing a sequence corresponding to the TSD and a portion not containing a sequence corresponding to the TSD includes distinguishing between half of the excised sequence. (Item A5) The method according to any of the above items, wherein step (B) further comprises a step of mapping the excised sequence onto a reference sequence to identify the genomic positions of a portion containing a sequence corresponding to the TSD and a portion not containing a sequence corresponding to the TSD. (Item A6) The method includes, before the step (B), a step of selecting different excision sequences from the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data, The method according to any of the above items, wherein the selection of a pair of excision sequences having the same TSD at the 5' end and the 3' end is performed from among excision sequences that are different between the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data. (Item A7) The method according to any one of the above items, further comprising a step of calculating the frequency of identical excision sequences in the set of excision sequences. (Item A8) The method according to any one of the above items, further comprising a step of excluding excision sequences having a frequency below a certain level from the set of excision sequences. (Item A9) The method according to any one of the above items, further comprising a step of identifying a transposable element sequence based on the transposable element correspondence pair. (Item A10) The method according to any one of the above items, further comprising a step of confirming the transposition activity of the transposition element. (Item A11) The method according to any one of the above items, wherein the transposition activity of the transposable element is confirmed by one or more methods selected from PCR, sequencing, and hybridization. (Item A12) The method according to any one of the above items, further comprising repeating steps (B) to (D) by changing n. (Item A13) The method according to any one of the above items, wherein n is 3 to 20. (Item A14) The method according to any one of the preceding items, wherein the constant length is 17 to 50 bases long. (Item A15) The method according to any one of the above items, wherein the corresponding transposable element partial sequence is a transposable element partial sequence having at least 90% identity. (Item A16) The method according to any one of the above items, wherein the corresponding transposable element partial sequence is a transposable element partial sequence having at least 95% identity. (Item A17) The method according to any one of the above items, wherein the corresponding transposable element partial sequences are identical transposable element partial sequences. (Item A18) A method according to any of the above items, wherein the step of generating a set of excised sequences includes excising the fixed length of sequence by shifting it by one base for the complementary strands of the first genome sequence data and the second genome sequence data. (Item A19) The method according to any one of the above items, wherein n is 5 or 8, and the constant length is 25 bases long. (Item A20) The method according to any one of the above items, wherein n is 5 or 8, and the constant length is 40 bases long. (Item A21) A method according to any of the above items, further comprising a step of identifying the presence or absence of insertion of the transposable element partial sequence and / or the insertion position of the transposable element partial sequence by comparing the insertion position of the transposable element with a reference sequence in an individual other than the individual having the TSD based on the transposable element correspondence pair. (Item A22) A method according to any of the above items, further comprising a step of identifying the presence or absence of insertion of the transposable element partial sequence and / or the insertion position of the transposable element partial sequence by mapping the insertion position of the transposable element onto a reference sequence based on the transposable element correspondence pair. (Item A23) A method for identifying a transposable element in a sequence, comprising: (A) A step of extracting X base sequences from short reads derived from two types of samples by shifting the sequences by one base; (B) obtaining the frequency of each of the obtained sequences of the plurality of X bases; (C) obtaining and comparing the positions of the first and second halves of each of the obtained sequences of a plurality of X bases on a reference sequence; A method comprising: (Item A24) The method according to any one of the preceding items, wherein the base length of the first half and the second half is X / 2 bases. (Item A25) The method according to any one of the preceding items, wherein X is 20 or more bases. (Item A26) A method for detecting target site duplications (TSDs) and / or junctions of transposable elements in a sequence, comprising: (A) A step of extracting X base sequences from short reads derived from two types of samples by shifting the sequences by one base; (B) obtaining the frequency of each of the obtained sequences of the plurality of X bases; (C) obtaining and comparing the positions of the first and second halves of each of the obtained sequences of a plurality of X bases on a reference sequence; A method comprising: (Item A27) The method according to any one of the above items, wherein the base length of the first half and the second half is X / 2 bases. (Item A28) The method according to any one of the preceding items, wherein X is 20 or more bases. (Item A29) A program for causing a computer to execute a method for identifying a transposable element in a sequence, the method comprising: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (d) selecting from the selected pairs a pair of excision sequences having corresponding transposable element partial sequences; (e) determining whether the first genomic sequence is a genomic sequence from the pair of excised sequences having corresponding transposable element partial sequences; selecting pairs of excision sequences having different TSDs as transposable element matching pairs from a set of excision sequences from the sequence data and a set of excision sequences from the second genome sequence data; Including, the program. (Item A30) A recording medium storing a program for causing a computer to execute a method for identifying a transposable element in a sequence, the method comprising: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (d) selecting a pair of excision sequences having corresponding transposable element partial sequences from the selected pairs; (e) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as transposable element corresponding pairs; A recording medium including: (Item A31) A system for identifying a transposable element in a sequence, the system comprising one or more processors, a memory, and a recording medium for storing a program, the program, when executed by the one or more processors, performs the following: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (d) selecting a pair of excision sequences having corresponding transposable element partial sequences from the selected pairs; (e) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as transposable element corresponding pairs; A system implementing a method including: (Item A32) A system for identifying a transposable element in a sequence, the system comprising: (A) a sequence data receiving unit that receives first genome sequence data and second genome sequence data; (B) extracting sequences of a certain length from the first genome sequence data and the second genome sequence data obtained by the sequence data receiving unit by shifting the sequences by one base at a time, and generating a set of sequences extracted from the first genome sequence data and a set of sequences extracted from the second genome sequence data; Each of the excision sequences is classified into a sequence corresponding to a target site duplication (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical is selected; From the selected pairs, a pair of excision sequences having corresponding partial sequences of transposable elements is selected; a transposable element matching pair selection unit that executes a step of selecting, from pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different sequences in the TSDs in a set of excision sequences from the first genome sequence data and a set of excision sequences from the second genome sequence data, as transposable element matching pairs; (C) a display section showing the transposable element correspondence pair; Including, the system. (Item A33) A nucleic acid having at least a partial sequence of a transposable element identified by the method according to any one of the above items. (Item A34) A nucleic acid according to any one of the above items, which has a recognition sequence for a transferase in the transposable element. (Item A35) Use of the nucleic acid according to any of the above items for introducing a mutation into a genome sequence. (Item A36) Use of a nucleic acid according to any one of the above items for gene disruption by transposition of a transposable element. (Item A37) Use of a nucleic acid according to any of the above items for controlling transcription. (Item A38) Use of the nucleic acid according to any of the above items for the production of an insertion mutant line. (Item A39) A method for identifying a transposable element in a sequence according to any one of the above items, the method comprising: (A) extracting a sequence of a fixed length of X bases+n bases from the first genome sequence data and the second genome sequence data by shifting the sequence by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (A1) sorting a set of excised sequences from the first genome sequence data and a set of excised sequences from the second genome sequence data, and outputting the sets of excised sequences together with their frequencies; (A2) removing sequences that overlap between the first genome sequence data and the second genome sequence from the set of excised sequences from the first genome sequence data and the set of excised sequences from the second genome sequence data, and selecting sequences that are specific to each of the set of excised sequences from the first genome sequence data and the set of excised sequences from the second genome sequence data; (B) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (candidate transposable element partial sequence), selecting, from among pairs of candidate transposable element partial sequences, a TSD on the 5'-end side of a candidate transposable element partial sequence having two or more types of TSD and a TSD on the 3'-end side of the candidate transposable element partial sequence, and selecting, from the selected data set, all pairs of excision sequences in which the TSD on the 5'-end side and the TSD on the 3'-end side are identical; (C) selecting pairs of excision sequences having corresponding transposable element partial sequences from the selected pairs, in which the 5'-side transposable element partial sequence candidates and the 3'-side transposable element partial sequence candidates and the corresponding TSDs are output in a line and sorted; (D) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data, as transposable element corresponding pairs, selecting a pair of candidate 5'-side transposable element partial sequences and 3'-side transposable element partial sequences in which the ratio of the TSD sequence specific to the first genome sequence data or the TSD sequence specific to the second genome sequence data to the TSD of the pair of candidate 5'-side transposable element partial sequences exceeds th, where th is 0.2 or more; (E) if the reference sequence is present, mapping the adjacent sequences at the 5' and 3' ends of the detected candidate transposable element partial sequence to identify the insertion position on the genome, or if the reference sequence is not present, confirming that the insertion is not present in the reference sequence corresponding to the assumed insertion site in a sample sequence other than the sample in which the insertion was revealed. A method comprising: (Item A39-1) The method according to any of the above items, further comprising: (C1) a step of excluding sequences in which any of A, C, G, or T bases is 1 or less in the 5'-side transposable element partial sequence candidate and the 3'-side transposable element partial sequence candidate. (Item A40) The method according to any one of the above items, wherein th is 0.7. (Item A41) The method according to any one of the above items, wherein n is 3 to 20. (Item A42) The method according to any one of the preceding items, wherein X is 17 to 50. (Item A43) (A) a step of extracting X base sequences from short reads derived from two types of samples by shifting the sequences by one base; (B) obtaining the frequency of each of the obtained sequences of the plurality of X bases; (B1) sorting and outputting each sequence of a plurality of X bases; (B2) extracting a sequence of X bases specific to either of the two types of samples; (C1) obtaining a position on a reference sequence corresponding to the first half X / 2 base sequence of each of the extracted X base sequences; (C2) obtaining a position on a reference sequence corresponding to the latter X / 2 base sequence of each of the extracted X base sequences; (C3) sorting the location data obtained in C1 and C2 by chromosome; (D) outputting, from the position data sorted in C3, data in which the junction positions are shifted to form TSDs and the length of the TSDs is equal to or greater than s1 and equal to or less than s2; (E) selecting a TSD adjacent to the 3'-end of the first X / 2 bases and a TSD adjacent to the 5'-end of the second X / 2 bases, in which there are two or more types of TSDs, and selecting from the selected dataset all pairs of sequences of the X bases in which the TSD adjacent to the 5'-end and the TSD adjacent to the 3'-end are identical; (F) selecting pairs of the X / 2 base sequences that are present in both of the two samples and have two or more different TSD sequences; (G) outputting the pairs selected in F from the position data obtained in C1 and C2; The method according to any of the above items, comprising: (Item A44) The method according to any one of the above items, wherein X is 20 or more. (Item A45) The method according to any one of the preceding items, wherein s1 is 3 or more. (Item A46) The method according to any of the preceding items, wherein s2 is 20 or less.

[0007] In the present disclosure, it is intended that one or more of the above features may be provided in combinations other than those explicitly stated. Still further embodiments and advantages of the present disclosure will be recognized by those skilled in the art upon reading and understanding the following detailed description, if necessary. Effect of the Invention

[0008] The method disclosed herein can detect the transposition of a new active transposon only by sequence analysis using a next-generation sequencer, without the need to compare it with a reference sequence. Although several techniques for detecting the transposition of a transposon with a known sequence using base sequence information are known, the method disclosed herein can accurately detect the new transposition of a new transposon whose sequence is unknown.

[0009] Since it can find active transposons even in organisms for which no reference genome sequence exists, it can be used to detect transposons and breed them in vegetables, fruit trees, and ornamental plants in addition to crops. In ornamental plants, it can be used to control variegation, and in crops, fruit trees, and vegetables, it can be used to increase yields, improve taste, and change harvest times by providing disease resistance and drought resistance. In animals, it can be used to identify various characteristics related to transposons (for example, conditions including diseases and disorders, or characteristics related to individuality), and to perform diagnosis and modify characteristics based on the identification. [Brief description of the drawings]

[0010] [Figure 1] FIG. 1 is a schematic diagram illustrating an embodiment of a system according to the present disclosure. [Diagram 2] FIG. 2 is a schematic diagram of a further embodiment of the system of the present disclosure. [Diagram 3] FIG. 3 is a schematic diagram of a transposition sequence identified by the method of algorithm 1 according to one embodiment of the present disclosure. [Figure 4] FIG. 4 is a schematic diagram of a transposition sequence identified by the method of Algorithm 2 according to one embodiment of the present disclosure. [Diagram 5] FIG. 5 is a schematic diagram showing the LTR arrangement of the retrotransposon Tos17. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011] The present disclosure will be described below while showing the best mode. Throughout this specification, the expression of the singular form should be understood to include the concept of the plural form, unless otherwise specified. Therefore, the singular article (for example, in the case of English, "a", "an", "the", etc.) should be understood to include the concept of the plural form, unless otherwise specified. In addition, it should be understood that the terms used in this specification are used in the sense commonly used in the field, unless otherwise specified. Therefore, unless otherwise defined, all technical terms and scientific and technical terms used in this specification have the same meaning as commonly understood by those skilled in the art to which this disclosure belongs. In case of conflict, the present specification (including definitions) will take precedence.

[0012] (definition) The following provides definitions of terms particularly used in this specification and / or explains basic technical content as appropriate.

[0013] In this specification, "or" is used when "at least one or more" of the items listed in the sentence can be employed. The same applies to "alternative." In this specification, when "within the range of" two values ​​is specified, the range includes the two values ​​themselves.

[0014] As used herein, a "sequence" refers to a number of variables each of which takes a certain value, and further includes information on the order of the number of variables. Typically, a sequence is displayed as a character string. Examples of sequences include, but are not limited to, nucleic acid sequences (substantially the same as DNA sequences, nucleotide sequences, etc.), amino acid sequences (substantially the same as peptide sequences, protein sequences, etc.), etc. Determining a sequence is called sequence determination or sequencing (or sequencing), etc., but these are synonymous.

[0015] As used herein, the term "subject sequence" refers to any sequence in which a polymorphism is to be detected, and may be referred to herein as "target," "target sequence," or "target." As used herein, the term "control sequence" refers to any sequence used as a standard for detecting differences from that sequence as polymorphisms, and may be referred to herein as "control," "reference sequence," "comparison sequence," or "control."

[0016] In this specification, the term "reference sequence" refers to a sequence that can be treated as the full-length sequence of a target sequence and / or a control sequence. The sequence to be used as the full-length sequence is appropriately determined depending on the sequence to be used as the target sequence and / or the control sequence, and is not limited to the examples given. For example, a whole genome sequence, a full-length chromosome sequence, a full-length gene sequence, a full-length plasmid sequence, a full-length exon sequence, a full-length protein sequence, etc., present in a database on the web, can be used as a reference sequence. In this specification, the first sequence, the second sequence, etc. may be indicated by ordinal numbers, but either may be referred to as the target sequence or either may be referred to as the reference sequence, but it should be noted that the target sequence and the reference sequence are assigned different ordinal numbers.

[0017] As used herein, the term "excised sequence" refers to a sequence obtained by extracting (excising) a portion from a certain sequence.

[0018] As used herein, "sequence data" refers to data that provides information about a certain sequence. Typically, the sequence itself can be called sequence data, and data that provides information about a part of a sequence (e.g., analytical data obtained by sequencing a genome sequence) is also included as sequence data.

[0019] As used herein, a "subsequence" of a sequence refers to any sequence contained within that sequence.

[0020] As used herein, a "subset" refers to any subset of a set that is a combination of a set of sequences and a set of subsequences of those sequences.

[0021] As used herein, "next-generation sequencing" refers to a sequencing technique that parallelizes the sequencing process and generates tens to hundreds of millions of sequence data in a single run. "Next-generation sequencer" refers to an instrument for performing next-generation sequencing.

[0022] As used herein, "eliminating coincidental identity" refers to reducing the expected value of a sequence that is identical to a given sequence by chance to less than 1.

[0023] As used herein, the term "coverage" refers to how many times the amount of sequence data corresponds to the full length of the sequence. It may also be referred to as "coverage rate" or "~ times the number of reads."

[0024] As used herein, the term "array structure" refers to a physically separated set of sequences in a sequence. For example, in the context of a genome sequence, each chromosome can be referred to as an array structure.

[0025] As used herein, "transposition" refers to the insertion of a transposable element into a sequence construct.

[0026] (transposable element) In one aspect, the present disclosure provides novel transposable elements and techniques for identifying them.

[0027] As used herein, the term "transposable element" refers to a base sequence that can transpose (transpose) a position on a genome. Transposable elements are roughly divided into DNA types in which DNA fragments are directly transposed, and RNA types that undergo the processes of transcription and reverse transcription. The former are transposons in the narrow sense, and the latter are also called retrotransposons (or retroposons). In this specification, when the term "transposon" is used simply, it is not intended to be limited to transposons in the narrow sense, and unless otherwise specified, it is understood to be used synonymously with transposable element.

[0028] For DNA transposons to transpose, an enzyme called transposase is required, which is encoded by the transposon itself. Transposons have an inverted repeat sequence at the end, which the transposase recognizes to cut the transposon out of the genome sequence and reinsert it into the appropriate genome sequence. After being transcribed, retroposons create cDNA from mRNA by the reverse transcriptase enzyme they encode, and are reinserted into the chromosome. Either type can cause mutations when inserted into a gene region, and DNA types can also induce chromosomal abnormalities by cutting out the surrounding DNA sequence during excision. In addition, incomplete transposition can leave junk sequences on the chromosome. The "RNA type" moves in a so-called copy-and-paste manner, while the "DNA type" moves in a so-called cut-and-paste manner.

[0029] RNA-type transposable elements include long terminal repeat (LTR) retrotransposons, endogenous retroviruses, long interspersed elements (LINEs), short interspersed elements (SINEs), and non-autonomous elements known as processed pseudogenes (PPs). DNA-type transposable elements include DNA transposons and small inverted repeat transposable elements (MITEs). When any of these elements are integrated into a new genomic location, the sequence of the target site may be duplicated. This duplication is referred to herein as "target site duplication" and may be abbreviated as "TSD". The length of this target site duplication is often unique to each transposable element. TSDs are generally 2-20 bp long, unidirectional repeat sequences. In this specification, sequences other than TSDs may be referred to as "transposable element partial sequences".

[0030] Transposons are abundant in the genome sequences of eukaryotes. Most are inactive and have been considered unnecessary junk until now, but in rare cases, some transposons may transpose, causing mutations. For example, it is known that the color of red and white wine grapes becomes white when a transposon is inserted into the anthocyanin synthase gene, causing it to lose activity (Science 304:982,2004). Among mutants in which the rice retrotransposon Tos17 has been transposed, new varieties such as "Akita Barari" and "Akita Sarari" have been developed that utilize the starch gelatinization properties of strains in which the starch biosynthesis gene has been mutated. If the transposition of transposons could be freely controlled, it would be possible to modify the functions of various genes, which would be of great industrial value, but it has been extremely difficult to find active transposons.

[0031] Methods for detecting active transposons include creating primers from consensus sequences specific to transposons such as reverse transcriptase genes and detecting transposon transfer from the transcription products (Hirochika H et al. (1996) Retrotransposons of rice involved in mutations induced by tissue culture, Proc Natl Sci US A., 93:7783-7788) and detecting transposons that happened to be inserted into a gene of interest (Nakazaki T et al. (2003) Mobilization of a transposon in the rice genome, Nature 421, 170-172). Isolation is performed using experimental molecular biology techniques.

[0032] (Method of identifying transposable elements) In one embodiment of the present disclosure, transposable elements can be identified, for example, as follows. Algorithm 1 (TSD method) 1. Short reads from two samples, A and B, are cut out to a size of 20 bases + the specified TSD, each shifted by one base. 2. Sort the extracted sequences and output them along with their frequencies. 3. Exclude sequences that are in both A and B and select sequences that are A-specific or B-specific. 4. The selected sequences are output as the TSD sequence (Head sequence) and the Tail sequence (TSD sequence), and the possible candidate sequences are output. 5. Select a dataset of Head and Tail sequences with two or more types of TSD from sequences that combine Head and Tail with TSD. 6. Create all combinations of Head and Tail sequences that have the same TSD. 7. Create a sorted file with Head_Tail and TSD for A and B printed on a single line. 8. Exclude sequences with one or less A, C, G, or T base in the head or tail sequence. 9. Select the Head_Tail pair for which the proportion of A-specific or B-specific TSD sequences in the TSD for the Head_Tail pair of interest exceeds th (for example, th is 0.2, in which case the program sets th > 0.2). 10. If a reference sequence is available, map the adjacent sequences of the detected Head and Tail sequences to determine the insertion position on the genome. 11. If no reference sequence is present, verify that the insertion is not present in a sequence corresponding to the predicted insertion site in a different sample sequence than the one in which the insertion was detected.

[0033] When using this method, th is typically a value of 0.1 or more, and may be 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, etc., and generally good results can be obtained with 0.7. Of course, if the conditions are too strict with th>0.7 and nothing can be detected, the threshold can be lowered for calculation. For example, in the example of detecting P elements in Drosophila, this example shows that transposition can be detected by setting the TSD size to 8 and lowering th>0.2.

[0034] Also, if there is no reference sequence, if there is no insertion of a transposable element in the sequence of another sample, it can be used as proof that transposition has occurred. For example, since the rice genome is diploid, in the generation immediately after transposition, the genotype of the new transposition will be heterozygous, and sequences without insertions can be detected in the sequences of samples in which insertions have been detected. In addition, in the case of ttm2 and ttm5, because they are the F4 generation that have been selfed four times, some transpositions are homozygous. In such cases, it is possible to confirm the presence of a transposition using a sequence from an individual other than the one in which transposition was detected.

[0035] In one embodiment, when analyzing sequences of organisms for which no reference sequence exists, the candidate terminal sequences of the detected transposable element can be used as a query to search sequences from two or more individuals to detect evidence of transposition.

[0036] In one embodiment, when a reference sequence is present, the insertion position can be identified by searching for the insertion flanking sequence against the 20-base sequence at every position of the reference sequence, which can also identify the insertion position in the repeat region.

[0037] When a transposable element is transposed and inserted into a genomic DNA sequence, it creates a duplication of several bases at the target site (Fig. 3a). In the case of algorithm 1, the sequence into which the transposable element is inserted is cut into pieces of a certain length, and among these are sequences containing target site duplications (TSDs) adjacent to the 5' and 3' ends of the transposable element. Since the TSD sequences differ for each insertion site, the 5' and 3' end sequences of the transposable element can be detected by grouping them by TSD sequences (Fig. 3b).

[0038] In one embodiment of the present disclosure, a transposable element can be identified as follows. Algorithm 2 (Junction Method) 1. Short reads from two samples, A and B, are cut into 40-base pairs, each shifted by one base. 2. Sort the extracted 40-base sequences and output them together with their frequency. 3. Extract a 40-base sequence specific to A or B. 4. Find the genomic position corresponding to the first 20 bases of the sequence. If the sequence contains 9 or more repeats of AC, AG, AT, TC, or TG, exclude them. 5. Find the genomic position of the latter 20 base sequence. Exclude sequences that contain 9 or more repeats of AC, AG, AT, TC, or TG. 6. After separating the first and second 20 bases of data by chromosome, sort them by position. 7. From the sorted data, the junction positions of each are shifted to form a TSD, and data with a TSD size of 4 to 10 is output. 8. Select a head and tail pair with multiple types of TSD. 9. Select a head and tail pair that exists in both A and B and has two or more different TSD sequences. 10. Select and output the selected head and tail pairs from the mapped data.

[0039] In this case, the number of bases to be cut out is not limited to 40 bases, and can be any length. For example, a length of 20 bases or more can be cut out. In one embodiment, when the cut-out base length is divided into the first half and the second half in steps 4 and 5, the positions of the first half and the second half on the reference sequence can be obtained by dividing the first half and the second half, and it is not necessary to divide it in half.

[0040] In one embodiment, when the cut-out base length is divided into the first and second halves at half the position, the base lengths of each part are the same, so that the reference data paired with the position data, which has been subdivided to the same length, can be searched for an exact match.

[0041] In the case of algorithm 2, the TSD in the first or second half of the excised sequence is found, and the transposon present in the adjacent site can be detected (Figure 4. For each of the excised sequences, in order of appearance, sequence numbers 29 to 40 are listed from top to bottom for individual A, and then from top to bottom for individual B).

[0042] In addition, retrotransposons generally have duplicated sequences called long terminal repeats (LTRs) at both ends, so that the sequence near the 5' end of the transposon is also present in the downstream LTR, and the sequence near the 3' end is also present in the 3' end of the upstream LTR (Figure 5).

[0043] Algorithm 1 allows you to specify the length of the TSD for analysis. Therefore, you can change the TSD length by one base and repeat the same analysis. Algorithm 2 maps the first 20 bases and the remaining 20 bases of a 40-base sequence onto the genome to detect junctions, and then matches the TSDs, so there is no need to specify the length of the TSD at first.

[0044] Furthermore, Algorithm 1 can detect transposition of transposable elements by comparing sequences from two samples even when there is no reference sequence. Algorithm 2 first maps to a reference sequence, and the original transposable element exists on the reference. Creating a reference sequence from an individual containing an active transposable element is difficult because inconsistencies occur in the assembly of the transposed transposable element sequence. As a result, there is a high possibility that an individual that does not normally have transposition activity of the transposable element will be selected for the reference sequence. Algorithm 2 can be applied to the detection of transposable elements that are activated and transposed only under special circumstances, such as Tos17 in rice.

[0045] Therefore, in one aspect of the present disclosure, a method for identifying a transposable element in a sequence (e.g., a nucleic acid sequence) is provided. It is known that a transposable element generates a target site duplication (TSD) of several bases when transposing. Therefore, it is considered that the sequences of both ends of the transposed transposable element are preserved. The method of the present disclosure can detect a transposable element in a sequence, at least in part, using this as a clue. The method of the present disclosure can detect a transposable element without requiring information on a reference genome sequence. For example, a transposable element can be detected from an analysis of short reads of a next-generation sequencer. The method of the present disclosure can be used to detect a transposable element with an unknown sequence. In addition, the method of the present disclosure can detect an active transposable element that is actually undergoing transposition.

[0046] In one aspect, the disclosure provides a method for identifying a transposable element in a sequence, the method comprising: (A) extracting sequences of a certain length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (B) classifying each of the excision sequences into a sequence corresponding to a target site duplication (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (C) selecting a pair of excision sequences having corresponding transposable element partial sequences from the selected pairs; (D) selecting, from pairs of excision sequences having corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in a set of excision sequences from the first genome sequence data and a set of excision sequences from the second genome sequence data, as transposable element corresponding pairs.

[0047] In this aspect of the present disclosure, a plurality of genome sequence data are compared to detect transposable elements that transpose between them.Typically, the first and second genome sequence data are compared, but more than two genome sequence data may be compared.For example, 2, 3, 4, 5, 8, 10 or more genome sequence data may be used.For example, about 10, about 15, about 20, about 50, about 100, about 200, about 500, about 1000 or more genome sequence data may be used.As one embodiment of the present disclosure, both (or either) of the first genome sequence data and the second genome sequence data can be mixed and analyzed with a plurality of genome sequence data from different origins.

[0048] The genome sequence data may be a reference genome sequence or may be sequencing data of a genome sequence. The genome sequence data may be recorded in a database or the like, or may be obtained by newly determining a sequence.

[0049] In one embodiment, the set of excision sequences may be generated by acquiring sequences of a fixed length while shifting the start position of each sequence in the genome sequence data by one base at a time. The fixed length may be, for example, within the range of 17 to 50 bases. An example of the fixed length is the size of 20 bases + TSD, for example, 23, 24, 25, 26, 27, or 28 bases. It is considered that the fixed length of 17 bases or more can eliminate the possibility of coincidence in the excision sequence. In addition, the longer the fixed length, the higher the accuracy, but the larger the amount of data to be handled. Although there is no problem in an environment that can handle large data, it is preferable to set the upper limit to about 35 to 50 bases. The constant length can be, for example, a base length in the range of 10 to 100, such as a base length in the range of 10 to 20, 20 to 30, 30 to 40, 40 to 50, 50 to 60, 60 to 70, 70 to 80, 80 to 90, or 90 to 100. The size of the TSD can be any length, for example, 3 to 20 bases.

[0050] In one embodiment, the step of generating a set of excision sequences may include excising the fixed length sequence from the complementary strand of the first genome sequence data and / or the second genome sequence data by shifting the sequence by one base at a time. Although not necessary when there is a sufficient amount of sequence data, by including the excision sequence of the complementary strand in the analysis, detection sensitivity can be increased when the amount of sequence data is small.

[0051] In one embodiment, the set of excised sequences is a collection of sequences of a certain length. The entire set may be used for analysis, but some sequences may be excluded from the analysis as necessary. Appropriately excluding sequences from the analysis not only avoids the effects of errors during sequencing, but also reduces the amount of calculation, which may be advantageous in handling large amounts of data. In the present disclosure, when an unknown base (generally represented as N) is included in the excised sequence, the sequence may be excluded from the analysis. may be excluded from

[0052] In an embodiment of the present disclosure, the method may further include a step of calculating the frequency of identical excision sequences from a set of excision sequences of a certain length. Furthermore, the method of the present disclosure may further include a step of excluding excision sequences with a frequency of a certain level or less. Preferably, excision sequences with a frequency of a certain level or less can be excluded when using a short-read genome sequence, and excision sequences with a frequency of a certain level or less do not need to be excluded when using an assembled genome sequence. The calculation of the frequency of identical excision sequences can be performed, for example, by sorting the excision sequences in lexicographical order. In addition, sequences with a certain number of identical sequences or less can be excluded from the analysis as being likely to contain sequencer errors. The reference frequency can be determined in consideration of the balance between the amount of sequence data and the genome size of the target organism (sequence coverage). For example, when the sequence coverage is 40, identical sequences can be excluded from the analysis when there are 1, 2, 3, 4, or 5 or less. In rice, empirically, by excluding identical sequences from the analysis when there are 5 or less, it is possible to almost eliminate coincidences of noise. In other embodiments, the sequence coverage can be any value, for example the sequence coverage can be 20.

[0053] In an embodiment, the method of the present disclosure may include a step of selecting different excision sequences from a set of excision sequences from the first genome sequence data and a set of excision sequences from the second genome sequence data. In the transposon that has undergone transposition, the sequence of the transposon is conserved, but the TSD sequence portion is considered to be different, so that the excision sequence containing the end of the transposon that has undergone transposition and the TSD sequence is considered to be specific to each genome sequence data. Therefore, it is considered that the set of the end of the transposon and the TSD sequence is included in the excision sequence selected here. This selection can be performed before the above step (B). The different excision sequences are typically excision sequences that are present in the set of excision sequences from the first genome sequence data and are not present in the set of excision sequences from the second genome sequence data, or that are present in the set of excision sequences from the second genome sequence data and are not present in the set of excision sequences from the first genome sequence data. However, excision sequences that are present in large numbers in the set of excision sequences from the first genome sequence data and present only in small numbers in the set of excision sequences from the second genome sequence data, or that are present in large numbers in the set of excision sequences from the second genome sequence data and present only in small numbers in the set of excision sequences from the first genome sequence data, can also be considered as different excision sequences.For example, when the abundance of the excision sequence is at least about 2 times, at least about 5 times, at least about 10 times, at least about 20 times, at least about 40 times, at least about 50 times, at least about 100 times, at least about 200 times, at least about 500 times, or at least about 1000 times, or more, it is possible to treat the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as different excision sequences.When the TSD is short, the possibility of a coincident occurrence is high, so on the other hand, in addition to a completely absent sequence, it may be preferable to consider a sequence with a certain or greater difference in abundance.For example, a three-base TSD has 64 possible combinations, which is thought to result in a considerable number of coincidences. To detect transposable elements more comprehensively, sequences with abundance differences of up to about 5-fold may be considered.

[0054] In one embodiment, the selection of pairs of excision sequences having the same TSD at the 5' end and the same TSD at the 3' end in step (B) can be performed from among excision sequences that are different between the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data, thereby greatly reducing the enormous amount of calculation required to detect pairs.

[0055] In an embodiment, the method of the present disclosure may include a step of distinguishing each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical. In consideration of the possible length of the TSD, the n base length may be set, for example, in the range of 3 to 20 (i.e., 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20), for example, in the range of 3 to 10 (i.e., 3, 4, 5, 6, 7, 8, 9, 10). Since the method of the present disclosure is considered to be effective in detecting a transposable element having a TSD of a base length set as n, the method may further include a step of repeating the steps of the method of the present disclosure (e.g., the above-mentioned steps (B) to (D)) by changing n.

[0056] The step of distinguishing an excision sequence into a sequence corresponding to a TSD and a transposable element partial sequence can be carried out by generating, from a certain excision sequence, a set of a sequence of n bases from the 5' side and the remaining sequence, and a set of a sequence of n bases from the 3' side and the remaining sequence. Since a TSD is generally a repeat in the same direction, it is possible to directly compare the 5'→3' sequence of the n bases from the 5' side with the 5'→3' sequence of the n bases from the 3' side to determine whether the TSD at the 5' end and the TSD at the 3' end are identical.

[0057] In one embodiment, it is believed that by selecting, from among pairs of sequences in which the above-mentioned 5'-end TSD and 3'-end TSD are identical, pairs that satisfy the following two conditions between the genome sequence data: (i) the sequences of the transposable element portions correspond; and (ii) the sequences of the TSD portions differ, it is possible to detect pairs of excision sequences that correspond to actual transposable elements.

[0058] In certain embodiments, the method of the present disclosure may further include a step of selecting a pair of excision sequences having corresponding transposition element partial sequences from the selected pair of excision sequences having the same TSD at the 5' end and the same TSD at the 3' end. Examples of corresponding transposition element partial sequences include transposition element partial sequences having at least about 90% identity, transposition element partial sequences having at least about 95% identity, transposition element partial sequences having at least about 97% identity, transposition element partial sequences having at least about 98% identity, transposition element partial sequences having at least about 99% identity, or identical transposition element partial sequences. Since the sequence of the transposition element portion may be mutated at the time of transposition, the processing may be performed while taking this into consideration, but if this is excluded from consideration and only the transposition element partial sequences that perfectly match are considered, it is also possible to reduce the amount of calculation and significantly reduce the time required for calculation.

[0059] In an embodiment, the method of the present disclosure may further include a step of selecting a pair of excision sequences having different TSDs in a set of excision sequences from the first genome sequence data and a set of excision sequences from the second genome sequence data from pairs of excision sequences having corresponding transposable element partial sequences. The pair selected in this step can be a transposable element corresponding pair. In this specification, the term "transposable element corresponding pair" refers to a pair of constant-length excision sequences that are considered to include the end of a transposable element and its outer TSD. For example, each excision sequence can be located on a reference sequence, or the sequence of the region between each excision sequence can be determined from genome sequence data. Thus, the method of the present disclosure may further include a step of identifying a transposable element sequence based on the transposable element corresponding pair.

[0060] The different TSD sequences are typically present in a pair of excised sequences from the first genome sequence data and not present in a pair of excised sequences from the second genome sequence data, or present in a pair of excised sequences from the second genome sequence data and not present in a pair of excised sequences from the first genome sequence data. A TSD sequence that does not exist in a pair of excision sequences from the first genome sequence data. However, a TSD sequence that exists in a large number in a pair of excision sequences from the first genome sequence data and exists in a small number in a pair of excision sequences from the second genome sequence data, or exists in a large number in a pair of excision sequences from the second genome sequence data and exists in a small number in a pair of excision sequences from the first genome sequence data, can also be considered as a different TSD sequence. For example, when the abundance of a certain TSD sequence differs by at least about 2 times, at least about 5 times, at least about 10 times, at least about 20 times, at least about 40 times, at least about 50 times, at least about 100 times, at least about 200 times, at least about 500 times, or at least about 1000 times, or more, the pair of excision sequences from the first genome sequence data and the pair of excision sequences from the second genome sequence data can be treated as different TSD sequences. If most of the TSDs are different between the first and second genome sequence data, the probability of a transposon is considered high. However, even if most of the TSDs are detected in both genomes, if only a few (e.g., only one) are different, this may be the result of a very low frequency of transposition, so such cases may also be detected.

[0061] In a further embodiment, once a candidate transposable element sequence is identified, a step of confirming the transposition activity of the transposable element can be performed, if necessary, by further using a known method. The transposition activity of the transposable element can be confirmed, for example, by performing an analysis between samples in which the transposition of the transposable element is thought to occur. For example, the transposition activity of the transposable element can be confirmed by a technique including one or more selected from PCR, sequencing, and hybridization. The transposable element can be confirmed by performing other transposable element detection techniques known in the art in combination. Examples of other transposable element detection techniques include Transposon Insertion Finder (TIF) (Nakagome M, Solovieva E, Takahashi A, Yasue H, Hirochika H, ​​Miyao A (2014) Transposon Insertion Finder (TIF): a novel program for detection of de novo transpositions of transposable elements. BMC Bioinformatics 5:71. doi:10.1186 / 1471-2105-15-71).

[0062] (Schematic embodiment) This section provides a schematic example of a method for detecting a transposable element. This section is provided for illustrative purposes and is not intended to limit the method of the present disclosure. Assuming that the TSD is 5 bases, and focusing on both ends of the transposon (20 bases each) and the TSD (5 bases), the sequence derived from the transposon is as follows on the genome: [ka] In the schematic diagram, "_" indicates the base sequence outside the transposon, and "+" and the base sequences corresponding to the Head and Tail parts indicate the base sequences of the transposon. If 25 bases are extracted from all bases of all short reads in the sequence data obtained by sequencing the genome, it is thought that it will include TSD-Head and Tail-TSD. Since transposon transposition is an independent event, when comparing the sequences of two individuals, the TSD sequences will be different even if the same transposon is transposed. Therefore, if a set of 25 bases with the same Head and Tail sequences and different TSDs between individuals is obtained from a 25-base sequence (5 TSD bases and Head or Tail 20 bases), the set is thought to be a set of both ends of the transposon and the TSD.

[0063] (Genome sequence data) In certain embodiments, in the present disclosure, two or more genome sequence data may be used as genome sequence data, which may be different due to transposition of transposable element.Since transposable element may transpose in the genome of a cell, genome sequence data may be used as genome sequence data from different cells of the same individual.In the present disclosure, genome sequence data from a single cell may be used.

[0064] Examples of combinations of origins of the first and second genome sequence data in the present disclosure include, for example, a first cell and a second cell of an individual, a first tissue and a second tissue of an individual, a first individual and a second individual of a species, a first population and a second population of a species, an individual under first and second conditions, a cell under first and second conditions, etc.

[0065] The biological species from which the genome sequence data of the present disclosure is derived are not limited in any way as long as they have a biological sequence. Some examples of animals include vertebrates such as humans or non-human mammals (e.g., mice, rats, rabbits, sheep, pigs, cows, horses, cats, dogs, monkeys, and chimpanzees), birds, reptiles, amphibians, and fish, and invertebrates such as insects and nematodes. Examples of plants include rice, wheat, corn, potatoes, barley, sweet potatoes, buckwheat, Arabidopsis thaliana, Lotus japonicus, tomatoes, cucumbers, cabbages, Chinese cabbages, eggplants, sugarcane, sorghum, apples, tangerines, bananas, peaches, poplars, pine trees, cedar trees, angiosperms, gymnosperms, ferns, mosses, and algae. Other examples include fungi, bacteria, and viruses. Genomic sequence data derived from a part of these organisms, such as tissues and cells, may be analyzed to detect transposable elements.

[0066] In one embodiment, the genome sequence data used in the method of the present disclosure is base sequence data obtained by sequencing.Sequencing techniques include Sanger sequencing, Maxam-Gilbert sequencing, single molecule real-time sequencing (e.g., Pacific Biosciences, Menlo Park, California), ion semiconductor sequencing (e.g., Ion Torrent, South San Francisco, California), pyrosequencing (e.g., 454, Branford, Connecticut), sequencing by ligation (e.g., SOLiD sequencing, Life Technologies, Carlsbad, California), synthetic and reversible terminator sequencing (e.g., Illumina, San Diego, California), nucleic acid imaging technology such as transmission electron microscopy, nanopore sequencing, etc.

[0067] In one embodiment, the genome sequence data used in the method of the present disclosure can be the sequence data obtained by next-generation sequencing.Next-generation sequencing includes sequencing by synthesis, pyrosequencing, sequencing by ligation, ion semiconductor sequencing, and nanopore sequencing.The detection of polymorphisms including transposable element differences from next-generation sequencing data is limited in accuracy by mapping to reference or assembly, so it is believed that the method of the present disclosure can be used to obtain great benefits.

[0068] The genome sequence data of the present disclosure may be any of the above genome sequence data obtained from a database or the like, or may be newly sequenced and used. As the genome sequence data, a set of output (reads) from a sequencer, a set of contigs made up of reads, a scaffold made up of contigs further joined together, or the genome sequence itself, or any combination thereof, may be used.

[0069] (Programs, recording media and systems) In one embodiment, a program for causing a computer to execute a method for identifying a transposable element in a sequence, the method comprising: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (d) selecting a pair of excision sequences having corresponding transposable element partial sequences from the selected pairs; (e) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as transposable element corresponding pairs; The program may be written in any language.

[0070] In another embodiment, a recording medium storing a program for causing a computer to execute a method for identifying a transposable element in a sequence, the method comprising: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (d) selecting a pair of excision sequences having corresponding transposable element partial sequences from the selected pairs; (e) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as transposable element corresponding pairs; A recording medium is provided, comprising: a program for executing the program; the program may be written in any language; in one embodiment, the recording medium may be an external storage device, such as a ROM that may be stored internally, a HDD, a magnetic disk, or a flash memory such as a USB memory; the recording medium may be non-transitory.

[0071] In another embodiment, a system for identifying transposable elements in a sequence is provided, the system comprising one or more processors, a memory, and a recording medium storing a program, the program, when executed by the one or more processors, performing the following: (a) receiving first genomic sequence data and second genomic sequence data; (b) extracting sequences of a fixed length from the first genome sequence data and the second genome sequence data by shifting the sequences by one base at a time, and generating a set of extracted sequences from the first genome sequence data and a set of extracted sequences from the second genome sequence data; (c) classifying each of the excision sequences into a sequence corresponding to a target site overlap (TSD) of n bases in length and a sequence other than the TSD (transposable element partial sequence), and selecting a pair of excision sequences in which the TSD at the 5' end and the TSD at the 3' end are identical; (d) selecting from the selected pairs a pair of excision sequences having corresponding transposable element partial sequences; (e) selecting, from the pairs of excision sequences having the corresponding transposable element partial sequences, pairs of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as transposable element corresponding pairs; A system is provided that implements the method including the steps of: The program may be written in any language. In one embodiment, the recording medium may be an external storage device such as a ROM that may be stored internally, a HDD, a magnetic disk, or a flash memory such as a USB memory. The recording medium may be non-transitory.

[0072] Next, the configuration of the system 1 of the present disclosure will be described with reference to the functional block diagram of Fig. 1. Note that, although the present disclosure shows a case where the system is realized by a single system, it will be understood that the present disclosure also includes a case where the system is realized by multiple systems.

[0073] The system 1000 of the present disclosure is configured by connecting a RAM 1003, an external storage device 1005 such as a ROM, HDD, magnetic disk, or flash memory such as a USB memory, and an input / output interface (I / F) 1025 via a system bus 1020 to a CPU 1001 built into a computer system. An input device 1009 such as a keyboard or mouse, an output device 1007 such as a display, and a communication device 1011 such as a modem are connected to the input / output I / F 1025. The external storage device 1005 includes an information database storage unit 1030 and a program storage unit 1040. Each of these is a certain storage area secured in the external storage device 1005.

[0074] In such a hardware configuration, various commands are input via the input device 1009, or commands are received via a communication I / F or communication device 1011, etc., and the software program installed in this storage device 1005 is called, expanded, and executed on the RAM 1003 by the CPU 1001, thereby performing the function of a method for detecting transposons in genome sequence data in cooperation with an OS (operating system). Of course, the present disclosure can also be implemented with mechanisms other than such cooperation.

[0075] In a specific embodiment, for the implementation of the present disclosure, genome sequence data may be input via the input device 1009, or may be input via a communication I / F or communication device 1011, or may be stored in the database storage unit 1030. Data of the identified pair of excised sequences may be output via the output device 1007 or may be stored in an external storage device 1005 such as the information database storage unit 1030. Next, the excision, comparison and / or selection of sequences may be performed by a program stored in the program storage unit 1040, or a software program installed in this external storage device 1005 by inputting various commands via the input device 1009, or by receiving commands via the communication I / F or communication device 1011, or the like. The results may be output via the output device 1007 or may be stored in the external storage device 1005 such as the information database storage unit 1030.

[0076] These data, calculation results, or information acquired via the communication device 1011 or the like are written and updated as needed in the database storage unit 1030. By managing information such as each sequence in each input sequence set and each gene information ID in the reference database in each master table, it becomes possible to manage information belonging to the sample to be accumulated by the ID defined in each master table.

[0077] Furthermore, the computer program stored in the program storage unit 1040 configures the computer as the above-mentioned processing system, for example, a system that performs processing such as detection of transposition elements. Each of these functions is an independent computer program, its module, routine, etc., and configures the computer as each system or device by being executed by the above-mentioned CPU 1001. Note that in the examples of the present disclosure, each function in each system cooperates to configure each system, and the program for this processing can also be provided via an external storage device, communication device, or input device.

[0078] Also, as shown in FIG. 2, the method of the present disclosure may be implemented by a computing system having a cluster structure. In one embodiment, the system has a cluster structure and is composed of a head and nodes. The nodes may use SSDs as their main storage devices to speed up searches. In one embodiment, one head may be operated with multiple nodes (for example, 12 nodes). In one embodiment, the computing system has a cluster structure, and a main computer (cluster head) is equipped with a large capacity storage device (HDD) to store analysis data and results. The cluster head sends the divided data to each node, which performs calculations, and the results are collected in the cluster head. Both the cluster head and the node may be equipped with a central control element (CPU) and memory (RAM), and may communicate data via a communication interface (NIC). The nodes may use solid state drives (SSDs) as their main storage devices to perform high-speed search processing. The CPU, RAM, SSD, etc., installed in each node may be shared with other nodes, or may be physically separated.

[0079] In another aspect, the present disclosure provides a system for identifying a transposable element in a sequence, the system including: (A) a sequence data receiving unit that receives first genome sequence data and second genome sequence data; and (B) a unit that extracts a sequence of a certain length from the first genome sequence data and the second genome sequence data obtained by the sequence data receiving unit by shifting the sequence by one base, generates a set of excised sequences from the first genome sequence data and a set of excised sequences from the second genome sequence data, and classifies each of the excised sequences into a sequence corresponding to a target site duplication (TSD) of n bases in length and a sequence other than the TSD (a transposable element). a transposable element matching pair selection unit that executes the steps of: distinguishing between pairs of excision sequences having the same TSD at the 5' end and the same TSD at the 3' end; selecting from the selected pairs a pair of excision sequences having corresponding transposable element partial sequences; and selecting from the pairs of excision sequences having corresponding transposable element partial sequences a pair of excision sequences having different TSDs in the set of excision sequences from the first genome sequence data and the set of excision sequences from the second genome sequence data as a transposable element matching pair; and (C) a display unit that displays the transposable element matching pairs.

[0080] In this aspect, the sequence data receiving unit can be realized by an input device 1009 included in the input / output I / F 1025, and the display unit is realized by an output device 1007 such as a display. The transposable element corresponding pair selection unit can be realized by any embodiment of the implementation method of the above method, and for example, a computer program stored in the program storage unit 1040 can realize the function of the transposable element corresponding pair selection unit by causing a computer to function as the above-mentioned processing system.

[0081] (Identified transposable elements) In a further aspect of the present disclosure, a nucleic acid is provided having at least a part (or may be the whole) of the sequence of the transposable element identified by the method of the present disclosure. The nucleic acid may have a recognition sequence for a transposase in the transposable element. It is believed that by identifying an element related to the transposition of a transposable element that is actually active in a genome sequence and introducing a nucleic acid containing the element, it can be used to introduce a mutation into the genome sequence. It is believed that by identifying an element related to the transposition of a transposable element that is actually active in a genome sequence and introducing a nucleic acid containing the element, it can be used for gene disruption by the transposition of the transposable element. Alternatively, it is believed that by identifying an element related to the transposition of a transposable element that is actually active in a genome sequence and introducing a nucleic acid containing the element, it can be used for transcription control. Since the transposable element transposes randomly throughout the entire genome, it is possible to use it to create an insertion mutant lineage that spans the entire genome.

[0082] In addition, in the present disclosure, a transposable element that is activated and transposed under certain conditions can also be used. For example, Tos17 is activated and transposed only during culture, but when the cultured cells are redifferentiated into a plant body, Tos17 is inactivated and does not transpose any more. If DNA is extracted from the same individual under certain conditions and other conditions and the analysis of the present disclosure is performed, and a transposable element is detected, the transposable element is considered to be a candidate for a transposable element that transposes under certain conditions.

[0083] An example of the application of the obtained transposon is koji mold transposon (e.g., https: / / www.jstage.jst.go.jp / article / jbrewsocjapan / 105 / 6 / 105_6_334 / _pdf). In this case, the transposon activity can be utilized to breed practical koji mold strains, and the technology of the present disclosure can be applied.

[0084] Retrotransposons can also be used to determine the variety of raw materials used in processed products, such as sweet potato products. For example, as mentioned in Breeding Research 6: 169-177 (2004) (https: / / www.jstage.jst.go.jp / article / jsbbr / 6 / 4 / 6_4_169 / _pdf), the replication sequences of retrotransposons are scattered throughout the genome and are known to be excellent genetic markers. Therefore, it is said that it is possible to identify all varieties of six Japonica rice varieties and six Indica rice varieties by using retrotransposons as multilocus probes. These technologies can be used to determine the variety of raw materials used in processed products.

[0085] In addition, as introduced in "Silkworm Technology: Evolving from a Clothing Revolution to a Medical Revolution" (https: / / www.yakult.co.jp / healthist / 213 / img / pdf / p02_07.pdf), the transposons identified in this disclosure can be applied to efficient genetic modification of insects. Furthermore, as introduced in "Characteristics and Industrial Use of Ion Beam Breeding Technology" (https: / / katosei.jsbba.or.jp / download_pdf.php?aid=268), it is possible to modify plants such as flowers, and the modifications can be strengthened by ion irradiation.

[0086] Furthermore, analysis of genome function can be performed by comprehensively producing mutant mice using transposons (for example, http: / / lifesciencedb.jp / houkoku / pdf / A-42_final.pdf), and this technology can be applied to the transposons of the present disclosure.

[0087] (application) The techniques provided in this disclosure for identifying transposable elements can be used to examine and identify events involving transposable elements.

[0088] For example, it is possible to diagnose and analyze the cognitive functions of the brain (see, for example, the report on the discovery of an acquired gene derived from a retrotransposon that is important for the cognitive functions of the brain (http: / / www.tmd.ac.jp / mri / press / press29 / index.html)). Here, for example, it has been demonstrated that the LTR retrotransposon-derived gene "SIRH11 / ZCCHC16" plays an important role in reactions such as attention and recognition in the mammalian brain, and such cognitive functions can be examined and analyzed using the method disclosed herein.

[0089] It can also be used to identify and analyze DNA mutations (see, for example, "Uncovering the mechanism by which DNA" moves on DNA - a movement strategy that cleverly utilizes host factors" (http: / / www.kyoto-u.ac.jp / ja / research / research_results / 2019 / 190829_1.html). Also, see Miyoshi T. et al., Molecular Cell, Volume 75, ISSUE 6, P1286-1298 (https: / / doi.org / 10.1016 / j.molcel.2019.07.018)). LINE is believed to suppress DNA mutations involved in canceration, and the present disclosure can be applied directly or indirectly.

[0090] Brain analysis can also be used to analyze the formation of the nervous system (for example, the ability to create new nerves in the adult brain - National Institute of Advanced Industrial Science and Technology (https: / / www.aist.go.jp / Portals / 0 / resource_images / aist_j / aistinfo / aist_today / vol10_05 / vol10_05_p12.pdf)). As reported individually, retrotransposons are mobile genes whose proportion in the genome has increased explosively since the evolution of mammals, and it has been reported that when the Wnt3a signal is activated, retrotransposon sequences are also activated, and it is believed that genes in the vicinity of retrotransposon sequences are indirectly affected by this signal, and that there are genes related to neurological diseases and important genes that regulate neurological functions. It is suggested that the present disclosure can also be applied to diagnosis and testing.

[0091] In addition, as reported in Chen, JM., Stenson, PD, Cooper, DN et al. Hum Genet (2005) 117: 411. (https: / / link.springer.com / article / 10.1007%2Fs00439-005-1321-0) and W' Waves Vol. 17 No. 1 2011 (http: / / www.npo-jsct.umin.jp / wwaves / WWAVES%20Vol.17_p044.pdf), it has been shown that various genetic diseases are caused by the transposition of a retrotransposon called Line-1 (Table 2), and it is understood that the method of the present disclosure can be applied to the diagnosis of these diseases (genetic diseases). Thus, the relationship of Line-1 with genetic diseases and cancer has been explained, and the method of the present disclosure can be applied to these diseases.

[0092] (General technology) The molecular biological techniques, biochemical techniques, microbiological techniques, and bioinformatics used herein may be any techniques that are known, well-known, or commonly used in the art.

[0093] All references cited herein, including scientific literature, patents, patent applications, and the like, are hereby incorporated by reference in their entirety to the same extent as if each was specifically set forth.

[0094] In the above, preferred embodiments have been shown and described to facilitate understanding of the present disclosure. The present disclosure will be described below based on examples, but the above description and the following examples are provided for illustrative purposes only and are not provided for the purpose of limiting the present disclosure. Therefore, the scope of the present disclosure is not limited to the embodiments or examples specifically described in this specification, but is limited only by the scope of the claims. EXAMPLES

[0095] Examples are described below. The handling of the organisms used in the following examples complied with the standards stipulated by the implementing organization and supervisory agency, if necessary. Although Perl is used as the programming language in the examples shown below, similar results can be obtained by using other programming languages.

[0096] (General Information Processing) The sequence information processing procedure performed in this example is described below. Two sets of genome sequence data (here, sequence data determined by a next-generation sequencer) were prepared for a target organism or individual, and analysis was performed in the following procedure.

[0097] 1. Extract sequences of 20 bases + TSD size from all positions of the sequence data of the next-generation sequencer. In this example, the size of the TSD is assumed to be 5 bases, and an analysis of a 25-base sequence is illustrated. The complementary strand sequence of the base sequence data is also extracted in the same manner. If N is included in the extracted 25 bases, it will not be included in the subsequent analysis.

[0098] 2. Sort the extracted 25-base sequences in lexicographical order and check the number of identical sequences.

[0099] 3. Sequences with five or fewer identical sequences are likely to contain sequencer errors, so only select sequences with a frequency of five or more.

[0100] 4. Compare the target and control sequence sets and select target-specific or control-specific 25-base sequences. The selected sequences should include the transposon ends and a set of TSD sequences.

[0101] 5. For all target or control specific sequences, cut into pairs of the first 20 bases and the remaining 5 bases. The first 20 bases are candidates for the 3' end of the transposon, and the remaining 5 bases are candidates for the TSD. Also, obtain the complementary strand sequence of the same 25 base sequence and cut into pairs of the first 5 bases and the remaining 20 bases. In this case, the first 5 bases are candidates for the TSD, and the remaining 20 bases are candidates for the 5' end of the transposon.

[0102] 6. Obtain a pair of 5'-end and 3'-end candidates with the same TSD sequence. Pairs of 5'- and 3'-end candidates with different TSD sequences may represent both ends of a newly transposon.

[0103] 7. Among the pairs of ends with different types of TSD sequences, obtain a pair in which the majority of the TSD sequences differ between the target and control. Identify this pair as corresponding to the end sequences of the newly transposed transposon.

[0104] In the following examples, we show detection of the transposition site in two Tos17 individuals with known sites, and detection of an unreported transposition in a ddm1 mutant. The system disclosed here is believed to be the first system in which such a phenomenon can be observed.

[0105] (Example 1: Detection of known transposons) ttm2 and ttm5 are mutant panel strains in which Tos17 activated by cell culture has been transposed. In this example, the genome sequence data of ttm2 and ttm5 were used for analysis. These genome sequence data were analyzed in Nakagome M, Solovieva E, Takahashi A, Yasue H, Hirochika H, ​​Miyao A. Transposon Insertion Finder (TIF): a novel program for detection of de novo transpositions of transposable elements. BMC Bioinformatics. 2014 Mar 14;15:71. doi: 10.1186 / 1471-2105-15-71. ttm2 is registered under the accession number SRR556173, and ttm5 is registered under the accession number SRR556174 and SRR556175.

[0106] These genome sequence data were processed as shown in (General Information Processing). The results are shown below.

[0107] The 5' end (first column) and 3' end (next column) of Tos17 were detected, and three TSDs (before |) were detected in ttm2 and eight TSDs (after |) in ttm5. The TSD sequences matched the sequences previously analyzed and reported. Two lines are output, but the second line is the complementary strand of the first line, so it can be seen that Tos17 is the only transposon that transposes in cell culture. [ka] (The 20 base sequences of the transposon end candidates correspond to SEQ ID NOs: 1 to 4 in order of appearance.)

[0108] As described above, the detected TSD matched the sequence detected in a previously reported experiment, demonstrating that this method can detect retrotransposon transposition.

[0109] (Example 2: Detection of unknown transposons) We tested whether the method disclosed herein can detect unknown transposons. Accession numbers DRR001193 and DRR001194 are genome sequences of Arabidopsis ddm1 mutants. The ddm1 mutant has reduced DNA methylation, and it is known that transposons are activated and transposed.

[0110] In this example, the sequences of DRR001193 and DRR001194 were analyzed, and the genome sequence data was processed as shown in (General Information Processing). The results are shown below. In the analysis of the ddm1 mutant, a transition that is thought to be a transposon that has not yet been reported was detected. [ka] [ka] (The 20 base sequences of the transposon end candidates correspond to SEQ ID NOs: 5 to 28 in order of appearance.)

[0111] Many of the above sequences are likely to be terminal sequences and TSDs of unknown retrotransposons. In other words, it has become clear that the method disclosed herein is effective for detecting transposition of the known transposon Tos17 as well. From this, it is believed that the method disclosed herein can detect the transposition of new transposons that have not been analyzed so far.

[0112] (Example 3: Modification method) The procedure was the same as that described in (General Information Processing), except for the part for obtaining the complementary strand sequence. Specifically, step "5." was modified as follows.

[0113] 5. For all target or control specific sequences, split into pairs of the first 20 bases and the remaining 5 bases. The first 20 bases are candidates for the 3' end of the transposon, and the remaining 5 bases are candidates for the TSD. Split into pairs of the first 5 bases and the remaining 20 bases of the same 25 base sequence. In this case, the first 5 bases are candidates for the TSD, and the remaining 20 bases are candidates for the 5' end of the transposon.

[0114] (result) The same results as in Example 1 were obtained. Specifically, the results are as follows: [ka] (The 20 base sequences of the transposon end candidates correspond to SEQ ID NOs: 1 to 4 in order of appearance.)

[0115] It was shown that similar results could be obtained without analysis of the complementary strand.

[0116] (Example 4: Application to cancer diagnosis) DNA is extracted from normal and cancer tissues of the same cancer patient, the base sequence is obtained, and transposons that metastasize in the cancer tissue are detected using this method.

[0117] Transposons are detected in multiple cancer patients, and transposons that are specifically activated by cancer are identified. If transposons that are activated by cancer are identified, they can be used to easily determine cancer.

[0118] It may be possible to diagnose cancer by extracting DNA or RNA from tissues of patients suspected of having cancer and detecting an increase in transposons.

[0119] We will identify transposable elements that can randomly induce gene mutations in vivo, create an insertion mutation screening system, and induce tumor formation. We will determine the genomic sequences of these tumors and identify the sites of insertion mutations to identify candidate genes involved in cancer formation and / or cancer malignancy. We will identify novel oncogenes and / or colon cancer suppressor genes by functionally evaluating the oncogenic potential of the candidate genes.

[0120] (Example 5: Use in creating mutant strains) Transposable elements are used to generate mutant line collections. For example, regarding the generation of Tos17 insertion mutant lines, see Miyao A, Tanaka K, Murata K, Sawaki H, Takeda S, Abe K, Shinozuka Y, Onosato K, Hirochika H. (2003) Target site specificity of the Tos17 retrotransposon shows a preference for insertion within genes and against insertion in retrotransposon-rich regions of the genome. Plant Cell 15(8):1771-80. Miyao A, Iwasaki Y, Kitano H, Itoh JI, Maekawa M, Murata K, Yatou O, Nagato Y, Hirochika H. (2007) A large-scale collection of phenotypic data describing an insertional mutant population to facilitate functional analysis of rice genes. Plant Mol Biol. 63(5):625-635, 2007. and Miyao A, Nakagome M, Ohnuma T, Yamagata H, Kanamori H, Katayose Y, Takahashi A, Matsumoto T, Hirochika H. (2012) Molecular spectrum of somaclonal variation in regenerated rice revealed by whole-genome sequencing. Plant Cell Physiol. 53(1):256-64. doi: 10.1093 / pcp / pcr172. Using the identified transposable elements, a similar mutant line collection can be created. The mutant line collection can be used for gene function analysis and acquisition of desired traits.For example, in the case of rice, it was discovered that suppressing a specific AGPase gene using a mutant line collection led to the accumulation of high levels of soluble sugar in the stems of plants, making it possible to produce plants with high soluble sugar content by accumulating high levels of soluble sugar in the stems of plants (Patent No. 5623324, "Plant mutants, method for producing plant mutants, and method for accumulating soluble sugar"); using a mutant line collection, a mutant in which the rice starch synthase type I (SSI) gene was knocked out was produced, which allowed the function of SSI to be elucidated and a new starch to be produced. ("Functional elucidation of starch synthase type I and method for producing novel starch", Patent No. 4703919); and, using a mutant line collection, starch synthase type IIIa (SSIIIa) mutants were isolated from a rice population, and mutants in which SSIIIa activity was completely absent compared to the wild type were obtained, and starch exhibiting physical properties such as gelatinization characteristics different from those of existing wild-type starches was obtained ("Functional elucidation of starch synthase type IIIa and method for producing novel starch", Patent No. 4711762). Similarly, mutant line collections produced using transposable elements identified by the method disclosed herein can be used for gene function analysis, acquisition of desired traits, and production of novel products therefrom.

[0121] Example 6: Detection of transposable elements in Arabidopsis hypomethylated mutants Transposable elements were detected in Arabidopsis hypomethylated mutants (DRR00193, DRR00194). Some of the results are shown in the table below. [Table 1] (The transposon sequences and adjacent sequences correspond to SEQ ID NOs: 41 to 88 in order of appearance, from left to right and top to bottom in each line.) The position where the insertion is at a unique position is marked as unique. Insertions into repeat regions have been difficult to detect until now, but the method disclosed herein can output possible positions from among multiple candidate positions.

[0122] (Example 7: Example of detection of transposition of retrotransposon Tos17) The transposition of retrotransposon Tos17 was detected by the method of the present invention, and some of the results are shown in the table below. [Table 2] (The head and tail sequences and adjacent sequences correspond to SEQ ID NOs: 89 to 128 in order of appearance, from left to right and top to bottom in each line.) The location where the insertion occurred at a unique location is marked as unique.

[0123] (Example 8: Detection of metastases at any TSD size) To confirm whether transpositions of any TSD size can be detected, Drosophila P elements SRR823377 and SRR823382 were analyzed. Some of the results are shown in the table below. . [Table 3] (The head and tail sequences and adjacent sequences correspond to SEQ ID NOs: 129 to 168 in order of appearance, from left to right and top to bottom in each line.) The location where the insertion occurred at a unique location is marked as unique.

[0124] (Example 9: Detection of transposition sequences using algorithm 2) The Tos17 insertion in ttm2 was detected by the method of algorithm 2. Some of the results are shown in the table below. [Table 4] (The terminal sequences and insertion site sequences correspond to SEQ ID NOs: 169 to 188 in order of appearance, from left to right and top to bottom in each line.) The original Tos17 exists in one copy each on chromosome 7 and 10. The 20-base sequence at the end of the transposable element exists at both ends of the long terminal repeats (LTRs) that exist at both ends of the transposable element, so two copies were detected on each side. The new algorithm was also able to detect the location on the genome of the original transposable element before transposition.

[0125] (Note) As described above, the present disclosure has been illustrated using preferred embodiments of the present disclosure, but it is understood that the scope of the present disclosure should be interpreted only by the claims. It is understood that the patents, patent applications and other documents cited in this specification should be incorporated by reference to this specification in the same manner as if the contents themselves were specifically described in this specification. This application claims priority to Japanese Patent Application No. 2019-236480 filed on December 26, 2019 in the Japan Patent Office, the contents of which are incorporated by reference in their entirety in this application. [Industrial Applicability]

[0126] Although the dynamics of transposons within an individual remains largely unknown, the method disclosed herein is capable of detecting transposons that are actually transposing, and has a wide range of applications. For example, the method can be used to screen transposons that can be used for transposon tagging in plants, and for humans, the method is thought to be useful in research into the relationship between cancer and transposons, and in research into activation and deactivation of gene transcription due to transposon transposition. [Sequence List Free Text]

[0127] SEQ ID NOs: 1 to 4: 20 base sequences of transposon end candidates described in Examples 1 and 4 (rice) SEQ ID NOs: 5 to 28: 20 base sequences of transposon end candidates described in Example 2 (Arabidopsis) SEQ ID NOs: 29 to 40: 20 base sequences of the excised sequence shown in FIG. 4 (rice) SEQ ID NOs: 41 to 88: 20 base sequences of the transposon sequence and adjacent sequences described in Example 6 (Arabidopsis) SEQ ID NOs: 89 to 128: 20 base sequences of head and tail sequences and adjacent sequences described in Example 7 (rice) SEQ ID NOs: 129 to 168: 20 base sequences of the head and tail sequences and adjacent sequences described in Example 8 (Drosophila) SEQ ID NOs: 169 to 188: Terminal sequences and insertion site sequences described in Example 9 (rice)

Claims

1. A method for identifying a transposable element in a sequence, comprising the steps of: (A) extracting X base sequences from short reads derived from two types of samples by shifting the sequences by one base; (B) obtaining the frequency of each of the obtained sequences of the plurality of X bases; (C) obtaining and comparing the positions of the first and second halves of each of the obtained sequences of a plurality of X bases on a reference sequence; A method comprising:

2. The method according to claim 1 , wherein the base length of the first half and the second half is X / 2 bases.

3. 3. The method of claim 1, wherein X is 20 or more bases.

4. 1. A method for detecting target site duplications (TSDs) and / or junctions of transposable elements in a sequence, comprising: (A) extracting X base sequences from short reads derived from two types of samples by shifting the sequences by one base; (B) obtaining the frequency of each of the obtained sequences of the plurality of X bases; (C) obtaining and comparing the positions of the first and second halves of each of the obtained sequences of a plurality of X bases on a reference sequence; A method comprising:

5. The method according to claim 4, wherein the base length of the first half and the second half is X / 2 bases.

6. The method according to claim 4 or 5, wherein X is 20 or more bases.

7. (A) extracting X base sequences from short reads derived from two types of samples by shifting the sequences by one base; (B) obtaining the frequency of each of the obtained sequences of the plurality of X bases; (B1) sorting and outputting each sequence of a plurality of X bases; (B2) extracting a sequence of X bases specific to either of the two types of samples; (C1) obtaining a position on a reference sequence corresponding to the first half X / 2 base sequence of each of the extracted X base sequences; (C2) obtaining a position on a reference sequence corresponding to the latter X / 2 base sequence of each of the extracted X base sequences; (C3) sorting the location data obtained in C1 and C2 by chromosome; (D) outputting, from the position data sorted in C3, TSDs each having a shifted junction position and a length of the TSD that is equal to or greater than s1 and equal to or less than s2; (E) selecting a TSD adjacent to the 3'-terminus of the first X / 2 bases and a TSD adjacent to the 5'-terminus of the second X / 2 bases, in which there are two or more types of TSD, and selecting, from the selected data set, all pairs of sequences of the X bases in which the TSD adjacent to the 5'-terminus and the TSD adjacent to the 3'-terminus are identical; (F) selecting pairs of the X / 2 base sequences present in both of the two samples and having two or more different TSD sequences; (G) outputting the pairs selected in F from the position data obtained in C1 and C2; The method of claim 1 or 4, comprising:

8. 8. The method of claim 7, wherein X is 20 or greater.

9. The method according to claim 7 or 8, wherein s1 is 3 or more.

10. The method according to any one of claims 7 to 9, wherein s2 is 20 or less.

Citation Information

Patent Citations

  • Method used for identification and quantitative low frequency somatic cell mutation detection

    CN108949911A

  • Utilization of rice transposon

    JP2006238804A

  • Transposon gene of rice plant

    JP2008187967A

  • Parallel functional testing of synthetic DNA segments, pathways, and genomes

    JP2019501642A

  • Method for identifying transposons from a nucleic acid database

    US20030152955A1